Document Type : Original Article

Authors

1 Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Pediatric Infections Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Department of Pediatric, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Anesthesiology, Imam Hossein General Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran

5 Department of Pediatric, Sarem Hospital, Tehran, Iran

6 Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Department of Obstetrics and Gynecology, Perinatology Division, Imam Hossein Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

BACKGROUND: The coronavirus, which is caused by acute respiratory syndrome, appeared in
Wuhan, China, in December 2019 and gradually spread around the world until almost all countries
became infected with the coronavirus. In Iran, the outbreak of coronavirus began on February 21,
2020, with the report of infection of two people in the city of Qom. The aim of this study is to evaluate
the clinical findings of neonates born to pregnant women with corona disease.
MATERIALS AND METHODS: During this case study (February 21 to November 30, 2020), out of
88 pregnant mothers who referred to the hospitals of Shahid Beheshti University of Medical Sciences,
44 live neonates were born from 42 pregnant women with COVID‑19, who were evaluated for clinical
signs by studying their files and reported as a case series, due to limited samples, No statistical
analysis of the study was performed.
RESULTS: In studies of clinical records of hospitalized mothers and infants, among the polymerase
chain reactions (PCRs) provided for all infants, one PCR was reported positive 2 days after birth,
whereas this infant 10 min after birth, immediately after routine procedures, due to positive mother’s
PCR was isolated from the operating room. However, all of the infant’s clinical symptoms were normal
during the 3‑day hospital stay for routine postpartum care. Twenty‑eight days after birth, the baby
was reevaluated for clinical, laboratory, and chest X‑ray symptoms, all of which were normal. The
PCR of other neonates was negative, and five intubated neonates, two twin, and two single died, and
the other neonates were discharged. In evaluating the clinical records of mothers of these infants,
the mean age is 30 years, and the average gestational age is 35 weeks, 32 cases of caesarean
section, and 10 cases of normal delivery.
CONCLUSION: We describe epidemiological data, demographics, signs and symptoms on
admission, laboratory results, comorbidities, infection COVID‑19 in the mothers and neonates,
chest radiography and computed tomography findings, treatment received for COVID‑19, and
clinical maternal, fetal, and neonatal outcomes. Due to the fact that the study population is
small consist of 42 mothers with COVID‑19 infection, among all PCR samples from infants
born to COVID‑19 positive mothers, the PCR result of one case was positive, and the rest of
was negative. Therefore, vertical transmission of COVID‑19 through the placenta to the fetus
cannot be confirmed or denied, nor can the COVID‑19 confirmed or denied the baby’s postnatal
complication during pregnancy.

Keywords

1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute
respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and
coronavirus disease‑2019 (COVID‑19): The epidemic and the
challenges. International journal of antimicrobial agents. 2020
Mar 1;55(3):105924.
2. Poon LC, Yang H, Lee JC, Copel JA, Leung TY, Zhang Y, et al.
ISUOG Interim Guidance on 2019 novel coronavirus infection
during pregnancy and puerperium: Information for healthcare
professionals. Ultrasound Obstet Gynecol 2020;55:700‑8.
3. AssiriA, AbediGR, Al MasriM, Bin SaeedA, Gerber SI, Watson JT.
Middle east respiratory syndrome coronavirus infection during
pregnancy: A report of 5 cases from Saudi Arabia. Clin Infect Dis
2016;63:951‑3.
4. Gajbhiye RK, Modi DN, Mahale SD. Pregnancy outcomes,
newborn complications and maternal‑fetal transmission of
SARS‑CoV‑2 in women with COVID‑19: A systematic review of
441 cases. MedRxiv. [Last accessed on 2020 Jan 01].
5. Malik A, El Masry KM, Ravi M, Sayed F. Middle East respiratory
syndrome coronavirus during pregnancy, Abu Dhabi, United
Arab Emirates, 2013. Emerg Infect Dis 2016;22:515‑7.
6. Wang S, Guo L, Chen L, LiuW, CaoY, Zhang J, et al. A Case Report
of Neonatal 2019 Coronavirus Disease in China. Clin Infect Dis
2020;71:853‑7.
7. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features
and obstetric and neonatal outcomes of pregnant patients with
COVID‑19 in Wuhan, China: A retrospective, single‑centre,
descriptive study. Lancet Infect Dis 2020;20:559‑64.
8. Chen D, Yang H, Cao Y, Cheng W, Duan T, Fan C, et al.
Expert consensus for managing pregnant women and
neonates born to mothers with suspected or confirmed novel
coronavirus (COVID‑19) infection. Int J Gynaecol Obstet
2020;149:130‑6.
9. Liao J, He X, Gong Q, Yang L, Zhou C, Li J. Analysis of
vaginal delivery outcomes among pregnant women in Wuhan,
China during the COVID-19 pandemic. Int J Gynecol Obstet
2020;150:53‑7.
10. Schwartz DA. An analysis of 38 pregnant women with COVID‑19,
their newborn infants, and maternal‑fetal transmission of
SARS‑CoV‑2: Maternal coronavirus infections and pregnancy
outcomes. Archives of pathology & laboratory medicine.
2020 Jul;144(7):799‑805.
11. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al.
Clinical analysis of 10 neonates born to mothers with 2019‑nCoV
pneumonia. Transl Pediatr 2020;9:51‑60.
12. Karimi‑Zarchi M, Neamatzadeh H, Dastgheib SA, Abbasi H,
Mirjalili SR, Behforouz A, et al. Vertical transmission of
coronavirus disease 19 (COVID‑19) from infected pregnant
mothers to neonates: A review. Fetal Pediatr Pathol
2020;39:246‑50.
13. Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: What
neonatologist need to know. J Med Virol 2020;92:564‑7.
14. Centro de Coordinación de Alertas y Emergencias Sanitarias.
Dirección General de Salud Pública. Ministerio de Sanidad.
Información científico‑técnica. Enfermedad por coronavirus,
COVID‑19. Actualización; 4 de abril 2020. Disponible from:
https://www.mscbs.gob.es/profesionales/saludPublica/
ccayes/alertasActual/nCov‑China/documentos/20200404_
ITCoronavirus.pdf. [Last accessed on 2020 Apr 04].
15. LiuW, Wang J, LiW, ZhouZ, Liu S, RongZ. Clinical characteristics
of 19 neonates born to mothers with COVID‑19. Front Med
2020;14:193‑8.
16. Salvatore CM, Han JY, Acker KP, Tiwari P, Jin J, Brandler M,
et al. Neonatal management and outcomes during the COVID‑19
pandemic: An observation cohort study. Lancet Child Adolesc
Health 2020;4:721‑7.
17. LiQ, GuanX, WuP, WangX, ZhouL, TongY, etal. Early transmission
dynamics in Wuhan, China, of Novel Coronavirus‑Infected
Pneumonia. N Engl J Med 2020;382:1199‑207.
18. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical
characteristics and intrauterine vertical transmission potentialof COVID‑19 infection in nine pregnant women: A retrospective
review of medical records. Lancet 2020;395:809‑15.
19. Xiao TT, Yan K, Wang LS, Zhou WH. What can we learn from
neonates with COVID‑19? World J Pediatr 2020;16:280‑3.
20. Ma K, Chen T, Han MF, Guo W, Ning Q. Management and clinical
thinking of Coronavirus Disease 2019. Zhonghua Gan Zang Bing
Za Zhi 2020;28:E002.
21. Zhu ZB, Zhong CK, Zhang KX, Dong C, Peng H, Xu T, et al.
Epidemic trend of COVID‑19 in Chinese mainland. Zhonghua
Yu Fang Yi Xue Za Zhi 2020;54:620‑4.
22. Tasnim Agency. Birth of a Neonate from Infected Mother
COVID‑19 in Babol City; March 3, 2020. Available from: https://
www.tasnimnews.com/fa/news/1398/12/14/2216407/. [Last
accessed on 2020 Mar 04].
23. Irani M, Pakfetrat A, Mask MK. Novel coronavirus disease 2019
and perinatal outcomes. J Educ Health Promot 2020;9:78.
24. BikdeliB, TalasazAH, RashidiF, Sharif‑KashaniB, FarrokhpourM,
Bakhshandeh H, et al. Intermediate versus standard‑dose
prophylactic anticoagulation and statin therapy versus placebo
in critically‑ill patients with COVID‑19: Rationale and design
of the INSPIRATION/INSPIRATION‑S studies. Thromb Res
2020;196:382‑94.